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Abstract
Background: Chronic cough has negative effects on quality of life. However, the changes in
health-related quality of life and clinical implications remain unclear in Chinese patients with chronic
cough.
Methods: A standard Chinese version of Leicester cough questionnaire (LCQ) was developed by
an established translation procedure and its repeatability was assessed in a preliminary study
involving 20 untreated patients with stable chronic cough. The quality of life was measured with the
Short form-36 health survey and compared between 110 patients with chronic cough and 90
healthy volunteers. The changes in health-related quality of life were evaluated in the patients with
chronic cough with the LCQ just before the specific treatment was initiated and a week after the
cough had resolved completely. Cough threshold with inhaled capsaicin, expressed as the lowest
concentration of capsaicin required for the induction of ≥5 coughs, was also measured.
Results: The repeatability of the Chinese version of the LCQ was validated at a four day interval
with the intraclass correlation coefficients of 0.89-0.94 for total and domain score (n = 20). The
scores of the Short form-36 health survey were significantly lower in patients with chronic cough
than those in healthy volunteers. In general, there was no significant difference in overall quality of
life between different causes of chronic cough or genders although embarrassment, frustration and
sleep disturbance were more common in female patients, as indicated by the LCQ. However, the
successful treatment of cough obviously increased the total scores of the LCQ from 14.2 ± 2.7 to
19.5 ± 1.9 (t = 13.7, P < 0.0001). There was a significant correlation between the total score of the
LCQ and physical (r = 0.39, P < 0.0001) or mental (r = 0.30, P < 0.001) component summary of the
Short form-36 health survey but not between the LCQ and capsaicin cough threshold.
Conclusion: The quality of life is significantly impaired in Chinese patients with chronic cough. The
Chinese version of the LCQ is a valid measure of cough related quality of life and is repeatable and
responsive.
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Background
Chronic cough is a common symptom that involves 20%-
38% of the patients seeking medical advice in the respira-
tory clinic [1,2], and a medical problem often faced by cli-
nicians. Persistent cough may cause organ injuries as well
as psychological and social dysfunction, thereby having a
profound adverse impact on quality of life [3]. With quan-
titative or semi-quantitative methods, the changes in the
health-related quality of life (HRQOL) provoked by
cough can be accurately analyzed, which is useful for
assessment of cough severity and therapeutic efficacy, and
can help to guide clinical practice and research in chronic
cough.
Cough symptom score, generic instruments such as the
Short form-36 health survey (SF-36), Sickness impact pro-
file and the other respiratory health questionnaires were
common tools for the evaluation of HRQOL in chronic
cough in early years [4]. Cough symptom score, although
simple and convenient, is not comprehensive while
generic instruments are troublesome and time-consum-
ing. Furthermore, lack of scores specific for cough or only
several items referring to cough in generic instruments
makes it difficult to precisely measure the tiny changes of
HRQOL caused by cough. To overcome these shortages,
the tools specific for assessments of HRQOL on chronic
cough have been designed, including the cough-specific
quality-of-life questionnaire [5], Leicester cough ques-
tionnaire (LCQ) [6] and chronic cough impact question-
naire [7]. The utilization of these instruments has greatly
promoted the studies of quality of life in chronic cough
patients.
It has been demonstrated that chronic cough has negative
effects on HRQOL of patients in many aspects including
physical, psychological and social domains, among which
the adverse impact on the psychosocial domain is the
most notable and possibly related to gender [5]. Success-
ful treatments not only relieve the symptoms of cough,
but also improve the quality of life [5,7,8]. However, the
current data on the HRQOL of chronic cough are only
from several western countries. The conclusions extrapo-
lated from these studies might not be suitable for the
patients in the other regions of the world because of dif-
ferences in the geography, ethnic, customs, cultural back-
grounds and lifestyle. Therefore, the purpose of the
present study was to investigate the changes in HRQOL in
Chinese patients with chronic cough.
Methods
Subjects
110 patients with chronic cough referred consecutively to
the Department of Respiratory Medicine in Tongji hospi-
tal were selected for the study. They were eligible for inclu-
sion in case of the presence of an isolated persistent cough
of > 8 weeks, the absence of adventitious lung sounds on
physical examination, normal findings on plain chest
radiography, a forced expiratory volume in 1 s (FEV1) >
80% of predicted and a ratio with forced vital capacity
(FEV1/FVC) >70%. Current smokers and ex-smokers of <
2 years were excluded.
90 healthy volunteers were enrolled from the staff and
medical students in the hospital. All of them were lifetime
non-smokers, had no history of chronic respiratory dis-
ease or allergic disease, had no upper respiratory tract
infections in the previous 2 months and did not currently
cough.
The general data of patients with chronic cough and
healthy volunteers were shown in Table 1. There was no
significant difference in age, the distribution of gender
and the variables of lung function between the two
groups. The hospital institutional ethics committee
approved the study, and all subjects gave informed con-
sent. The partial results of this study have been published
in a form of meeting abstract [9].
Methods and measurements
1. SF-36
A validated Chinese version of SF-36 [10] was employed.
The questionnaire is self-administered and composed of 8
multi-item scales (36 items) assessing physical function
(PF), role-limitations due to physical problems (RP),
Table 1: General data of chronic cough group and healthy control group
Items Chronic cough group Healthy volunteers
Cases 110 90
Male/female 36/74 40/50
Ages (yr) 47 ± 14 47 ± 12
Cough duration (month, range) 9(2-360) 0
FEV1(% predictive value) 95 ± 15 98 ± 12
FVC (% predictive value) 123 ± 16 120 ± 18
FEV1/FVC (%) 81 ± 7 83 ± 9
FEV1: forced expiratory volume in one second; FVC: forced vital capacity.Cough 2009, 5:7 http://www.coughjournal.com/content/5/1/7
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social function (SF), bodily pain (BP), role-limitations
due to emotional problems (RE), mental health (MH),
general health (GH) and vitality (VT). Generally, it took
less than 5 minutes for patients to complete. For each
multi-item scale, item scores are coded, summed and
transformed on to a scale from 0 (worst health) to 100
(best health) [11], then got a standard score of 0-100 [12].
Among them, PF, RF, BP and GH make up the physiolog-
ical domain, and these 4 items derive the physical compo-
nent summary (PCS). In contrast, RE, VT, MH and SF
comprise the psychosocial domain and derive the mental
component summary (MCS) [13]. The higher score
means better quality of life.
2. LCQ
After obtaining the written permission from the designer
of LCQ, Dr Birring, we translated it to standard Chinese.
The translation followed an established forward-back-
ward translation procedure, with independent transla-
tions and counter-translation. Independent translations
into Chinese of LCQ by two doctors specialized in respi-
ratory medicine were pooled to a common version. A psy-
chiatric doctor fluent in English translated this
provisional Chinese version back into English. This back
translation was found to be almost identical to the source
document. The Chinese version of LCQ was then finally
determined [see Additional file 1]. LCQ consists of 19
items, involving physical, psychological and social
domains, and each item represents an adverse event
caused by cough [6]. A 7-point Likert scale is used for scor-
ing the answer. Like SF-36, LCQ is also designed for self-
administration and needs less than 5 minutes for its com-
pletion, a higher score reflects better health status.
A preliminary study was performed to validate the repeat-
ability (test-retest reliability) of the Chinese version of
LCQ over time. The reliability was assessed by administer-
ing the LCQ to 20 untreated patients with stable chronic
cough at baseline and four day later when the patients did
not feel that their cough had changed.
3. Cough sensitivity test with capsaicin
cough sensitivity was measured according to the method
described by Fujimura [14] with minor modifications.
Briefly, the patient inhaled an aerosolized control solu-
tion of physiological saline followed by progressively
increasing double concentrations (0.49-1000 μmol/L) of
the capsaicin solution (Wako Pure Chemical Ind., Japan),
delivered through a PARI BOY N085 air-compressed neb-
ulizer (PARI GmbH, German) at an output rate of 0.5 ml/
min with a mass median diameter of the particles in 3.7
μm. Each concentration of solution was inhaled by tidal
mouth-breathing for 15 s, the number of cough was
counted from the initiation of a 15 s inhalation of capsa-
icin solution to a subsequent 45 s observation time. The
cough threshold was defined as the lowest concentration
of capsaicin required for the induction of ≥5 coughs (C5).
When the maximal concentration of capsaicin was
attained and the subjects had no cough, 1000 μmol/L was
assumed as a value of C5.
Study design and follow up
The etiologies of chronic cough were identified and
treated by our established protocol [15]. Just before the
specific treatment was initiated, SF-36 and LCQ were
filled out by the patients under the guidance of doctors
and capsaicin cough threshold C5 was detected. HRQOL
assessed with the LCQ was re-evaluated one week after the
patients reported that their cough had completely
resolved with successful treatment specific for the etiology
of the chronic cough.
Statistical analysis
The data was expressed as   ± s except for duration of
cough and cough threshold C5 which were presented as
median (range). Comparisons of variables between the
patients with chronic cough and healthy volunteers were
made using unpaired t-tests while the difference of gender
distribution was examined using X2 analysis. Changes in
HRQOL before and after treatment were analyzed by
paired t tests. Comparisons between the different etiolo-
gies of chronic cough were performed with one way anal-
ysis of variance followed by q-test. The repeatability of
Chinese version of LCQ was analyzed by calculating intra-
class correlation coefficients of LCQ total and domain
scores between the two evaluations. The relationships
between log transformed cough threshold C5 (Log C5)
and LCQ or SF-36 score were calculated using Spearman
rank order correlation coefficient. SPSS 10.0 software
(SPSS Inc., Chicago, IL, USA) was used for statistical cal-
culations. A P-value < 0.05 was considered significant.
Results
Validation of repeatability on the Chinese version of LCQ
The intraclass correlation coefficient of LCQ repeatability
was 0.94 (95% confidence interval: 0.85-0.98, P = 0.000)
for total score, 0.89 (95% confidence interval: 0.73-0.96,
P = 0.000) for the physical domain score, 0.93 (95% con-
fidence interval: 0.82-0.97, P = 0.000) for the psychologi-
cal domain score and 0.92 (95% confidence interval:
0.79-0.97, P = 0.000) for the social domain score respec-
tively.
HRQOL in patients with chronic cough
HRQOL in 110 patients with chronic cough, as repre-
sented by scores of SF-36, was significantly poorer than
xCough 2009, 5:7 http://www.coughjournal.com/content/5/1/7
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that in 90 healthy volunteers. Among the multi-item
scales of SF-36, RE, GH and RP were affected in the most
outstanding way (Table 2).
Differences of HRQOL between different etiologies of 
chronic cough
The causes of chronic cough in 110 patients were shown
in Table 3. Beside the single cause, cough symptoms in 10
patients could be explained by two causes, including 4
cases of cough variant asthma (CVA) plus upper airway
cough syndrome (UACS), 4 cases of CVA plus gastro-
esophageal reflux disease (GERD) and 2 cases of UACS
plus GERD. The other causes consisted of one case of envi-
ronmental factor related cough, 3 cases of angiotensin-
converting enzyme inhibitor-induced cough and 7 cases
of idiopathic cough. There were no significant differences
in HRQOL between the different etiologies of chronic
cough, whether measured with LCQ (Table 3) or with SF-
36 (Table 4).
Differences of HRQOL between males and females with 
chronic cough
When evaluated by LCQ, no significant difference in
HRQOL was found between males and females as a
whole, despite that the feelings of embarrassment, frustra-
tion and disturbance of sleep were more obvious in
women than in men (Table 5).
Effects of specific treatment on HRQOL of patients with 
chronic cough
In 103 patients who got a definite diagnosis for their
cough and received the specific treatments, cough
resolved completely in 86 patients. Five patients did not
respond to the treatment and 12 patients were lost to fol-
low-up and were therefore excluded for the further analy-
sis of the data. As measured with LCQ, the successful
treatment of chronic cough obviously improved HRQOL
of patients in the physical, psychological and social
domains (Table 6). The time intervals between pre- and
post-treatment evaluations were 3.9 ± 1.5 (range 2-13)
weeks.
Relationships between LCQ and SF-36 or cough threshold 
C5
There was a weak but significant correlation between the
total score of LCQ and PCS (r = 0.39, P < 0.0001) or MCS
(r = 0.30, P < 0.001) of SF-36 respectively. The median of
cough threshold C5 was 3.9 μmol/L (0.49 - 62.5 μmol/L,
Table 2: Comparison on scores of SF-36 between chronic cough group and healthy control group
Items Chronic cough group (n = 110) Healthy volunteers (n = 90) t value P value
PF 88.9 ± 10.6 95.2 ± 6.7 5.1 0.000
RP 66.3 ± 34.5 92.0 ± 25.3 5.6 0.000
RE 44.5 ± 36.5 92.6 ± 21.0 11.6 0.000
VT 70.8 ± 16.6 86.7 ± 10.0 8.3 0.000
MH 75.8 ± 14.6 87.3 ± 9.8 6.7 0.001
SF 84.9 ± 16.7 93.9 ± 9.9 4.6 0.000
BP 89.5 ± 10.7 92.2 ± 10.1 1.9 0.063
GH 58.8 ± 18.4 83.8 ± 13.4 10.7 0.000
PCS 60.3 ± 5.0 66.2 ± 4.3 8.8 0.000
MCS 57.6 ± 5.6 66.0 ± 3.8 12.7 0.000
Abbreviation: PF, Physical function; RP, role-limitations due to physical health; SF, social function; BP, bodily pain; RE, role-limitations due to 
emotional problems; MH, mental health; GH, general health; VT, vitality; PCS, physical component summary; MCS, mental component summary
Table 3: HRQOL comparison of LCQ scale between different causes of chronic cough (n = 110)
Causes Cases Total score Physical domain Psychological domain Social domain
UACS 10 14.5 ± 0.7 4.6 ± 0.2 4.4 ± 0.3 5.5 ± 0.3
CVA 54 14.2 ± 0.4 4.6 ± 0.1 4.3 ± 0.1 5.3 ± 0.2
GERD 6 13.7 ± 0.7 3.9 ± 0.5 4.5 ± 0.3 5.3 ± 0.3
NAEB 10 13.7 ± 1.0 4.5 ± 0.3 4.1 ± 0.4 5.2 ± 0.5
PVC 9 14.9 ± 1.4 4.8 ± 0.3 4.6 ± 0.6 5.5 ± 0.6
Two causes 10 12.8 ± 0.8 4.5 ± 0.3 3.9 ± 0.3 4.4 ± 0.4
Others 11 13.9 ± 0.8 4.4 ± 0.3 4.2 ± 0.3 5.4 ± 0.3
F value 0.57 0.61 0.44 0.99
P value 0.75 0.72 0.85 0.43
Abbreviation: CVA, cough variant asthma; UACS, upper airway cough syndrome; GERD, gastroesophageal reflux disease; NAEB, nonasthmatic 
eosinophilic bronchitis; PVC, post virus coughCough 2009, 5:7 http://www.coughjournal.com/content/5/1/7
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95% confidence interval: 8.0-9.3 μmol/L). No significant
correlation was found between Log C5 and LCQ (r =
0.134, P = 0.253), PCS (r = -0.092, P = 0.43) or MCS (r =
-0.22, P = 0.06) of SF-36.
Discussion
The quality of life is an important outcome parameter in
the study of chronic cough. To investigate HRQOL of Chi-
nese patients with chronic cough, we compared the scores
of items in SF-36 between patients with chronic cough
and healthy volunteers. The reasons for selection of SF-36
were that SF-36 is one of the most common instruments
in general health survey, its reliability and validity have
been established with extensive application [16]. Moreo-
ver, the measurements by the specific instruments such as
LCQ reflect HRQOL in the patients with chronic cough
well, but do not accurately represent the health status in
healthy volunteers because of lacking cough, which might
result in the poor comparability in HRQOL between
coughers and non-coughers. Finally, SF-36 has been used
for the assessment of the quality of life in the other
chronic respiratory diseases such as asthma and chronic
obstructive pulmonary disease, and always achieved great
success [17,18].
The results showed that the quality of life in patients with
chronic cough deteriorated significantly when compared
with healthy volunteers. The scores of patients with
chronic cough were lower in 7 testing multi-item scales of
SF-36 except for physical pain than those of healthy vol-
unteers. Among the affected domains, the decrease in the
scores of RE, GH and RP related to emotional problems
was more obvious. These observations were in accordance
with previous reports on HRQOL in patients with chronic
cough [5-8,19].
There was comparable HRQOL among the patients in
spite of causes of chronic cough, which confirmed the
findings of French and Canonica who had observed that
HRQOL in the chronic coughers was unrelated to the
causes of cough [8,20]. The impact of cough on quality of
life was to a large extent dependent upon the frequency
and intensity of cough [5]. Our previous study has also
shown that the cough severity was not significantly differ-
ent among different causes of chronic cough [21].
Although the pathogenesis of chronic cough is associated
with the cause, airway inflammation and increased sen-
sory nerve sensitivity in the airway is a common pathway
Table 4: Comparison on physical and mental component 
summary of SF-36 between different etiologies (n = 110)
Causes Cases PCS MCS
UACS 10 61.9 ± 5.2 58.3 ± 6.2
CVA 54 60.6 ± 4.7 57.8 ± 5.8
GERD 6 62.0 ± 5.3 57.8 ± 5.0
NAEB 10 59.6 ± 4.1 55.9 ± 6.3
PVC 9 60.5 ± 5.0 55.9 ± 5.8
Two causes 10 59.7 ± 6.3 56.4 ± 5.6
Others 11 57.6 ± 5.5 57.1 ± 4.4
F value 0.92 0.44
P value 0.48 0.85
Abbreviation: CVA, cough variant asthma; UACS, upper airway cough 
syndrome; GERD, gastroesophageal reflux disease; NAEB, 
nonasthmatic eosinophilic bronchitis; PVC, post virus cough; PCS, 
physical component summary; MCS, mental component summary
Table 5: Gender differences in HRQOL of patients with chronic cough as measure by LCQ (n = 110)
Adverse events caused by chronic cough Males Females t value P value
Chest or stomach pains 5.3 ± 1.7 5.5 ± 1.7 -0.32 0.75
Phlegm 4.5 ± 2.3 4.6 ± 2.3 -0.17 0.86
Tiredness 5.2 ± 1.6 4.7 ± 1.8 1.28 0.20
Controlled by cough 3.2 ± 1.7 3.1 ± 1.8 0.44 0.66
Embarrassment 4.9 ± 1.6 3.7 ± 1.6 4.02 0.00
Anxiety 4.5 ± 1.9 4.2 ± 1.6 1.01 0.32
Interference with job/other daily tasks 5.2 ± 1.6 5.1 ± 1.8 0.29 0.78
Interference with overall enjoyment 5.4 ± 1.7 5.4 ± 1.7 0.11 0.92
Cough by exposure of paints or fumes 3.8 ± 2.4 3.9 ± 2.2 -0.22 0.83
Disturbance of sleep 5.2 ± 1.9 4.4 ± 1.9 2.16 0.03
Coughing bouts 3.1 ± 1.3 3.1 ± 1.2 -0.16 0.88
Frustration 5.1 ± 1.7 4.5 ± 1.5 2.02 0.04
Feed up 4.2 ± 1.9 4.2 ± 1.6 0.05 0.96
Hoarse voice 5.5 ± 1.4 5.3 ± 1.6 0.65 0.52
Full of energy 4.8 ± 1.6 4.6 ± 1.8 0.78 0.44
Worry about serious diseases 4.4 ± 1.9 4.3 ± 1.7 0.49 0.63
Concerned the others' feelings about your cough 4.8 ± 2.0 5.4 ± 1.6 -1.70 0.09
Interrupted conversation or telephone calls 5.3 ± 1.6 4.8 ± 1.5 1.68 0.10
Annoying partner, family or friends 5.5 ± 1.9 5.5 ± 1.7 -0.08 0.94Cough 2009, 5:7 http://www.coughjournal.com/content/5/1/7
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and may play an important role [22,23]. Therefore, it is
reasonable that different causes eliciting chough result in
the similar cough severity and HRQOL in the cohort of
patients.
Gender is one possible factor determining the quality of
life of patients with chronic cough. Most studies have
demonstrated that women accounted for the majority of
patients with chronic cough seeking medical care, with
the ratio of 1:1.2-3.6 between males and females [24,25].
It seems that negative HRQOL caused by cough was more
conspicuous in women than in men, and might be attrib-
uted to the predominance of females in the patients with
chronic cough [26]. In contrast, the present study showed
that only several adverse events including embarrassment,
frustration and sleep disorder were more apparent in
women than men as measured with LCQ, and did not
confirm the gender difference in overall HRQOL of
patients with chronic cough. The selecting bias of patients
should not be an explanation since we recruited the
patients consecutively. It is likely that in previous studies
reporting gender differences in HRQOL, female patients
were coughing more frequently than men, and in this
study, coughing bouts were identical in men and women.
Another possibility is that the quality of life in the patients
with chronic cough visiting hospital was affected in a sim-
ilar level regardless of gender. Women with chronic cough
were more likely to see a doctor than men because of
embarrassment and the other psychosocial issues pro-
voked by cough-related urinary incontinence [26]. How-
ever, it only explains more females in patients with
chronic cough seeking medical advice. When a man went
to hospital due to his cough, it meant that his HRQOL was
decreased to a level comparable with females, thereby not
leading to the significant differences in HRQOL between
men and women.
When cough resolved with successful treatment specific
for the cause, the quality of life in the patients could be
significantly improved as judged by total score and
domain scores in LCQ, which is in accordance with the
previous study [5]. Therefore, HRQOL assessments of
chronic cough, as a precise and quantitative measure-
ment, could be applied in monitoring of cough severity,
evaluation of treatment efficacy and verification of new
therapeutic regimen.
Birring and Kalpaklioglu have found that there was a neg-
ative correlation between LCQ and the other tools such as
cough symptom score and visual analogue scale respec-
tively [6,27]. Recently, Kelsal has demonstrated that a cor-
relation existed between LCQ and cough frequency
recording [28]. Our study has shown that there was a weak
but significant correlation between LCQ and SF-36. The
similar relationship was verified between SF-36 and a
Dutch version of LCQ [29]. These evidences suggest that
LCQ, like the other cough-specific instruments, could
accurately measure the HRQOL changes in patients with
chronic cough. As indicated by our data, the Chinese ver-
sion of LCQ is helpful for evaluation of the health status
in Chinese patients with chronic cough.
There was no obvious correlation between LCQ and cap-
saicin cough threshold, which was similar to the results
reported by Birring [6] and Chang [30]. It may be due to
the different implications of HRQOL and capsaicin cough
sensitivity in assessment of cough severity. Capsaicin
cough threshold mainly represents the susceptibility of
cough while HRQOL reflects the perception of multidi-
mensional damage caused by cough. Therefore, HRQOL
and capsaicin cough threshold may measure different
aspects of the severity of cough and can be complemented
by each other.
Conclusion
In conclusion, HRQOL is adversely affected by chronic
cough but improves when cough resolves. In general, the
changes in HRQOL are not related to the causes of cough
and gender differences although some negative emotions
are more obvious in female Chinese patients. The Chinese
version of LCQ is useful tool for evaluation of the health
status in Chinese patients with chronic cough.
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